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1Cell Physiology, Ruhr-University Bochum, Bochum, Germany, 2Ophthalmology, Ludwig Maximilian University of Munich,
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The odorant receptor 51E2 (OR51E2), which is well-characterized in prostate cancer cells
and epidermal pigment cells, was identified for the first time as the most highly expressed
OR in human fetal and adult retinal pigment epithelial (RPE) cells. Immunofluorescence
staining and Western blot analysis revealed OR51E2 localization throughout the cytosol
and in the plasma membrane. Additionally, immunohistochemical staining of diverse
layers of the eye showed that the expression of OR51E2 is restricted to the pigment
cells of the RPE and choroid. The results of Ca2+-imaging experiments demonstrate
that activation of OR51E2 triggers a Ca2+ dependent signal pathway in RPE cells.
Downstream signaling of OR51E2 involves the activation of adenylyl cyclase, ERK1/2 and
AKT. The activity of these protein kinases likely accounts for the demonstrated increase in
the migration and proliferation of RPE cells upon stimulation with the OR51E2 ligand β-
ionone. These findings suggest that OR51E2 is involved in the regulation of RPE cell
growth. Thus, OR51E2 represents a potential target for the treatment of proliferative
disorders.
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INTRODUCTION
The retinal pigment epithelium (RPE), a monolayer of pigmented polarized cells, is located between
the choroids and the neural retina and represents a part of the blood-retina barrier (Rizzolo, 1997;
Marmorstein, 2001). The RPE performs a variety of important functions that are essential for
visual perception, such as light absorption, transepithelial transport, isomerization of all-trans to
11-cis retinal, secretion, and phagocytosis (Steinberg, 1985; Miller and Edelman, 1990; Bok, 1993;
Stalmans and Himpens, 1997; Baehr et al., 2003; Besch et al., 2003; Strauss, 2005). Most of these
functions are controlled by the intracellular Ca2+ level, which, in turn, is regulated via G protein-
coupled receptors (GPCR) (Wimmers et al., 2007). The genes coding for the odorant receptors
(OR) were first demonstrated to be expressed in the olfactory epithelium of the rat, where they
provide the elevation of intracellular calcium upon odor stimulation. These genes also represent
the largest GPCR family in the human genome (Buck and Axel, 1991). OR expression is found in
various human tissues outside the nose, such as the prostate, lung, liver, skin and testis (Feldmesser
et al., 2006; Zhang et al., 2007; Flegel et al., 2013). The physiological roles of these ectopically
expressed ORs are the subject of ongoing research. The few studies investigating their function
show that the activation of human ORs leads to, for example, secretion processes or influences the
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cell proliferation such as OR51E2 in prostate cancer cells or in
melanocytes (Spehr et al., 2003; Braun et al., 2007; Neuhaus et al.,
2009; Veitinger et al., 2011; Sanz et al., 2014; Kang et al., 2015;
Kim et al., 2015; Gelis et al., 2016; Kalbe et al., 2016b; Manteniotis
et al., 2016b; Tsai et al., 2017; Weber et al., 2017). The various
physiological functions depend on the tissue and respective OR.
In the olfactory sensory neurons, ORs mediate a calcium influx,
resulting in the generation of action potentials, which provide
a crucial step that leads to olfactory perception (Nakamura
and Gold, 1987). The activation of ectopically expressed ORs
results, in most cases also, in an increase of the intracellular
Ca2+ level, but this is not always directly linked to the observed
function. Interestingly, a recent transcriptome analysis revealed
the cell specific expression of ORs in the human neural retina
(Jovancevic et al., 2017b). In addition to the human neural retina,
ORs were identified in the human fetal RPE. Moreover, Ma
and colleagues identified a mutation in an OR gene expressed
in stem cell-derived human RPE cells that is associated with
the autosomal dominant retinitis pigmentosa (Ma et al., 2015).
However, subsequent commentaries on this study point out the
limits of the data obtained by whole-exome sequencing (Zhang
andHuang, 2015; Sharon et al., 2016). Early in their development,
RPE cells undergo a terminal differentiation, resulting in a
minimal proliferation capacity throughout normal life. However,
RPE cell proliferation can be induced in disease conditions
by a variety of growth factors (Stern and Temple, 2015). The
activation of proliferation leads to a repair of RPE layer defects.
However, an enhanced proliferation and migration could also
be pathological and lead to proliferative vitreoretinopathy, a
common cause of visual loss (Qiu et al., 2013).
The purpose of the present study was to investigate the ectopic
expression of ORs in the human RPE and the effects of OR
activation on intracellular Ca2+ level and physiological processes,
such as migration and proliferation.
MATERIALS AND METHODS
Cell Culture
Primary retinal pigment epithelial cells from different human
donors (3–10 h postmortem) without any history of eye disease
were obtained from the Eye Bank of Ludwig Maximilian
University and were prepared as previously described (Kernt
et al., 2009). We followed the guidelines of the declaration of
Helsinki, patients provided informed consent to the scientific
use of the explanted tissue, and the study was approved by the
local ethics boards of the clinical and the experimental study
contributors (Nr. 331-09). RPE cells were maintained in DMEM
(Gibco R©, Life Technologies) supplemented with 10% FBS and
100 units/ml penicillin and streptomycin at 37◦C in a 5% CO2
humidified atmosphere.
Transcriptome Analysis
For the transcriptome analysis, the RNA from human RPE cells
was isolated using the RNeasy Plus Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s protocol, including
the DNaseI digestion. The mRNA isolation from the total
RNA and sequencing analysis were performed by GENterprise
Genomics (Mainz, Germany) using the Illumina sequencing
platform as paired end (RPE1-2) or single reads (RPE3). The
datasets are available under the following NCBI Sequence
Read Archive accession numbers: SRR6253241, SRR6253242,
SRR6253243. We analyzed the mRNAseq data as previously
described (Flegel et al., 2013). The raw sequence data were
aligned to the human reference genome hg19 using TopHat
(Trapnell et al., 2009). Bowtie, the ultra-fast short-read mapping
program, served to arrange the alignment (Langmead et al.,
2009). The BAM-files were sorted and indexed using the
Samtools software package (Li et al., 2009). The FPKM
(fragments per kilobase of exon per million fragments mapped)
values were calculated using Cuﬄinks (Trapnell et al., 2010). We
reanalyzed previously published raw data in the same manner to
compare with the data newly generated for this study. We used
datasets from retina supporting tissue (RPE/Choroid/Sclera)
(Li et al., 2014) and from the human fetal retinal pigment
epithelium samples that were available in the NCBI SRA
archive under the following accession numbers: retina supporting
tissue (SRR1067930, SRR1067934, SRR1067937, SRR1067940)
and human fetal retinal pigment epithelium (SRR447138,
SRR786439). The datasets were summarized, and the expression
data are presented as the means of the FPKM values (mFPKM).
The neural retina raw data were taken from an earlier study
(Jovancevic et al., 2017b). All the datasets were equivalently
analyzed with the same parameters. The datasets were visualized
and investigated by the Integrative Genomic Viewer (http://
software.broadinstitute.org/software/igv/) for proving sequence
alignments and for the correct mapping of reads for the top
expressed genes. We determined a cutoff value of 0.3 FPKM for
OR expression as described in Jovancevic et al. (2017b).
While the raw data analysis was performed on a Linux
based computer, further calculations were carried out with
Microsoft Excel R© (Microsoft, WA, USA) and SigmaPlot 12.3
(Systat Software Inc., San Jose, CA, USA).
Reverse Transcription Polymerase Chain
Reaction
The total RNA from human RPE cells was reversely transcribed
using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories,
Hercules, CA, USA) according to themanufacturer’s instructions.
The equivalent of ∼50 ng of RNA was used for each of the
RT-PCR experiments. The PCR was performed under standard
PCR-conditions with the Mastercycler ep Gradient S (Eppendorf,
Hamburg, Germany) (20 µl total volume, 40 cycles: 95◦C, 59◦C,
72◦C, 45 s each). All experiments were conducted in triplicate.
The primers used for RT-PCR were as follows: OR51E2 (5′-act
gccttccaagtcagagc-3′ and 5′-cttgcctcccacagcctg−3′), PMEL (5′-
gtggtcagcacccagcttat-3′ and 5′-gaggagggggctgttctcac-3′), RLBP1
(5′-gctgctggagaatgaggaaactc-3′ and 5′-ggctggtggatgaagtggat-3′),
GNAL (5′-cagaccaggac-ctcctcaga-3′ and 5′-agggactctctcagcctgtt-
3′), ADCY3 (5′-aaggattcaaccctgggctc-3′ and 5′-tccagcgtcgcatctcat
ag-3′), CNGA2 (5′-atctccttgccgatgtccc-3′ and 5′-tacatgcagttccga
aaggtca-3′), CNGA4 (5′-gaggtgctgagcgagtatcc-3′ and 5′-cagccgttc
aatgcggtaag-3′) and CNGB1 (5′- cgtagagaaggtgatcccgc-3′ and 5′-
gtctgaggcagcacctgtag-3′).
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Antibodies
The following primary antibodies were used: custom-made
rabbit polyclonal antibody against OR51E2 (Eurogentec; epitope:
ISCDKDLQAVGGK); mouse monoclonal antibody against
glycerinaldehyde-3-phosphate-dehydrogenase (GAPDH; cat.
no. #ab9485; Abcam); rabbit monoclonal antibody against
PCNA (cat. no. #ab18197; Abcam); polyclonal rabbit anti-
Gαs/olf antibody (cat. no. #sc-383; Santa Cruz Biotechnology,
Dallas, Texas; USA), polyclonal rabbit anti-adenylyl cyclase III
antibody (cat. no. #sc-588; Santa Cruz Biotechnology); rabbit
monoclonal antibody against phospho-AKT (cat. no. #4060),
AKT (cat. no. #4691), phospho-ERK1/2 (cat. no. #4370) and
ERK1/2 (cat. no. #4695) (Cell Signaling Technology, Danvers,
Massachusetts, USA); secondary goat-anti-rabbit and goat-anti-
mouse antibodies conjugated to Alexa Fluor 546 or Alexa Fluor
488 (Life Technologies).
Immunocytochemistry
RPE cells were seeded on coverslips and maintained as described
above and human retina normal tissue slides were purchased
from Abcam. The specimens were fixed by incubation in 4%
paraformaldehyde at 4◦C for 30min. Afterwards, the cells
were washed and permeabilized in PBS+Triton X-100 (PBST).
Blocking was performed in PBST+1% gelatin and 5% goat
serum for 1 h at room temperature. The cells were then
incubated overnight with the primary antibody in PBST+1%
gelatin and 2% goat serum at 4◦C. For visualization, secondary
fluorescent anti-rabbit/mouse IgG antibodies (Life Technologies;
1:1,000 dilution) and 40,6-diamidino-2-phenylindole (DAPI)
were used. MaxBlock Autofluorescence Reducing Reagent Kit
(Dianova, Hamburg, Germany) was used to reduce potential
autofluoresence signal according manufacturer’s instruction.
Micrographs were taken by using a LSM510 Meta confocal
microscope (Zeiss, Jena, Germany).
Cell Surface Protein Isolation
Biotinylation and isolation of cell surface proteins for Western
blotting analysis were performed using the PierceTMCell Surface
Protein Isolation kit according to the manufacturer’s instructions
(Thermo Fisher Scientific, Waltham, Massachusetts, USA).
Western Blot
RPE cells were homogenized in lysis buffer (50mm Tris
HCl, pH 7.4, 150mm NaCl, 1mm EDTA, 1% Triton X-100)
with Complete R© protease inhibitor mixture and PhosSTOPTM
(Roche, Basel, Switzerland) using the Precellys R©24 (Bertin
Technologies, Montigny-le-Bretonneux, France) and Precellys
Ceramic Kit 1.4/1.8 (peglab, Erlangen, Germany). Samples were
loaded onto a SDS gel and Western blot analysis was performed
as described by Gelis et al. (2016).
Detection of Protein Phosphorylation
Cells were grown in T25 flask until reaching 70–80% confluence
and afterward treated with the appropriate concentration of
β-ionone or solvent only (0.1% DMSO) for 10 or 30min in
a humidified incubator at 37◦C. After a washing step with
PBS−/−, protein isolation was performed as described under
“Western Blot.” Detection of relative phosphorylation levels
of specific kinases was conducted with the Proteome Profiler
Human Phospho-Kinase Array Kit (R&D Systems, Minneapolis,
Minnesota, USA) according to manufacturer’s protocol or by
Western blot with phospho-specific antibodies according to
manufacturer’s instructions. Detection was done as described
in Gelis et al. (2016). The protein levels were quantified using
the Java-based ImageJ 1.46 software (Schneider et al., 2012) and
the relative pixel intensities of odorant-stimulated samples were
normalized to the relative pixel intensities of DMSO-treated
samples.
Ca2+ Imaging
RPE cells were incubated for 30min at 37◦C in loading buffer
(pH 7.4) containing Ringer’s solution (125mM NaCl, 5mM
KCl, 1mM MgSO4, 2.5mM CaCl2, 1mM KH2PO4, 10mM
NaHCO3 and 20mM HEPES) and 7.5µM Fura-2-AM (Life
Technologies). After removal of extracellular Fura-2 by washing
with Ringer’s solution, ratiofluorometric Ca2+ imaging was
performed using a Zeiss inverted microscope equipped for
ratiometric imaging and a Polychrome V monochromator (TILL
Photonics, Graefelfing, Germany). Cells were visualized with
a 20× objective (UPLSAPO, Olympus, Tokio, Japan). Images
were acquired in randomly selected fields of view at 0.5Hz
and integrated fluorescence ratios (f340/f380) were measured
using TILLvisION software (TILL Photonics). Odorant was pre-
diluted in DMSO and then diluted in Ringer’s solution to the
final concentration, so that the DMSO concentration did not
exceed 0.1% (v/v), which is tolerated by RPE cells. SQ 22,536
and other substances (Sigma-Aldrich, St. Louis, Missouri, USA)
were pre-diluted in DMSO unless otherwise by the manufacturer
indicated. Basic statistical analysis was performed in Microsoft
Excel and SigmaPlot.
cAMP Assay
Fifty to seventy percent confluent RPE cells were stimulated
for 30min with different concentrations of β-ionone, forskolin
(10µM) or solvent only. To detect the cAMP levels of
stimulated cells, the cAMP-GloTM Assay (Promega, Madison,
Wisconsin, USA) was used according to the manufacturer’s
instructions.
Cell Proliferation Assay
RPE cells were seeded in 96-well plates at density of 5× 103. After
24 h at 37◦C with 5% CO2 cells were stimulated with different
concentration of β-ionone or solvent DMSO (control) alone in
DMEM. Cell proliferation was investigated after 5 days using
the CyQUANT cell proliferation assay kit (Life Technologies).
For the visualization of proliferating cells via PCNA staining,
cells were treated for 5 days with β-ionone (10 and 100µM) or
solvent only. Afterward, cells were stained with anti-proliferating
cell nuclear antigen (PCNA) antibody (1:500) as described under
“Immunocytochemistry” and Alexa Fluor 546 phalloidin (Life
Technologies; 1:200).
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Gap Closure Assay
Confluent RPE cells grown in monolayers were scratched using
a sterile pipette tip and treated with β-ionone or solvent DMSO
(control) in DMEM and DMEM+5% FBS (positive control) for
48 h at 37 ◦C with 5% CO2. The residual overgrowing gap of the
migrating cells at 12, 24, and 48 h was measured and quantified
relative to the initial scratch area (0 h) with the TScratch software
(www.cse-lab.ethz.ch).
Statistical Analysis
Statistical analyses were performed with Microsoft Excel and
Sigma Plot 12. All results were tested for normality (Shapiro–
Wilk test) and equal variance. The significance levels were
calculated with a two-tailed unpaired t-test, and significant
values classified as ∗p ≤ 0.05, ∗∗p ≤ 0.01 and ∗∗∗p ≤ 0.005.
The dose–response curve and the EC50 value were calculated
using the 3-parameter Hill equation. The data were represented
as the mean ± SEM (standard error of the mean) from at least
three independent experiments.
RESULTS
Olfactory Receptor 51E2 Is Expressed in
the Human Retinal Pigment Epithelium
To generate a more complete view of OR expression in the
human RPE, we used mRNA sequencing to characterize the
OR expression profile of primary RPE cells from three different
healthy donors (Supplementary Table S1) and compared them
to reference tissue samples (self-generated data sets of neural
retina). In addition, we reanalyzed publicly available data sets
from fetal RPE and neural retina supporting tissues. According
to our analyses, OR51E2 was the highest expressed OR transcript
in human adult RPE cells and fetal RPE as well as in neural
retina supporting tissue, consisting of RPE, choroid and sclera.
In the human neural retina, OR51E2 transcripts were not
detectable (Figure 1A). Via the Integrative Genomic Viewer, we
confirmed the gene expression of OR51E2 by the detection of
the expression of a non-translated upstream exon (Figure 1A).
The detection of annotated 5’UTRs and the corresponding
exon-spanning reads is a good proof of the presence of
the OR transcript (Flegel et al., 2015a,b). In addition to the
OR51E2 transcript, only one further olfactory receptor, more
precisely OR2W3, was clearly detectable in two out of the
three RPE samples. Apart from the expression level, OR51E2
represent an interesting target for the characterization of an
OR in RPE cells because it is also one of the few human
ORs for which ligands (β-ionone, short chain fatty acids and
androstenone derivatives) have been identified (Neuhaus et al.,
2009; Saito et al., 2009). Therefore, we focused on investigating
the function of OR51E2 in primary RPE cells. First, we
validated the results of the mRNAseq analyses using RT-PCR
and detected the transcript expression of OR51E2 in primary
human RPE cells (Figure 1B, Supplementary Figure S1). To
confirm the protein expression of OR51E2, immunofluorescence
staining of the primary RPE cells with specific custom-
made antibodies was performed. The antibody specificity was
demonstrated by co-immunocytochemical staining of Hana3A
cells heterologously expressing rho-tagged OR51E2 (Gelis et al.,
2016; Massberg et al., 2016). OR51E2 was predominantly
located in the cytosol (Figure 1C). To deduce if OR51E2
was expressed at the plasma membrane in a low amount,
which may be difficult to detect, we analyzed cell surface
preparations of primary RPE cells by Western blot analysis.
Here, we clearly detected protein localization at the plasma
membrane of primary RPE cells (Figure 1D, Supplementary
Figure S6). Primary melanocytes served as the positive control
for the detection of OR51E2 protein abundance (Gelis et al.,
2016). Immunohistochemical analyses of histological sections
of human RPE, choroid and sclera further confirmed OR51E2
protein expression in the RPE (Figure 1E). Moreover, OR51E2
was also identified in the choroid, another pigment layer
of the eye.
OR51E2 Activation in Primary RPE Cells
The activation of OR51E2 by its agonist β-ionone induces a
rise in cytosolic Ca2+ level in epidermal melanocytes, melanoma
cells and prostate cancer cells (Neuhaus et al., 2009; Gelis et al.,
2016, 2017). As a first step in the functional characterization
of OR51E2 in RPE cells, we analogously investigated the
effects of short-term (2–5min) β-ionone stimulation on the
intracellular Ca2+ levels in primary RPE cells via the Ca2+
imaging technology. Stimulation of Fura-2-loaded RPE cells
with β-ionone resulted in an increase in intracellular Ca2+
concentration with no sensitization of the signal observed in the
repetitive stimulation. However, during the whole application
of β-ionone, the intracellular Ca2+ concentration reaches its
maximum and decreases to the cell’s basic Ca2+ level again
(Figure 2A). The β-ionone-induced cytosolic Ca2+ response was
dose-dependent in amplitude and number of activated cells
(Figures 2B–D). The EC50 value was 91µM, and the threshold
concentration to trigger a cellular response by β-ionone was
under 10µM (Figures 2C,D). Further OR51E2 agonists also
evoked a Ca2+ response in RPE cells, whereas compounds
that were inactive on the heterologously expressed OR51E2,
such as valeric acid, did not affect the intracellular Ca2+ level
(Supplementary Figure S2). The solvent (0.1% DMSO) did not
exhibit any effect when applied alone (Figure 2C). To determine
whether the β-ionone-induced Ca2+ signals were mediated by
OR51E2, we tried to perform RNA silencing experiments with
OR51E2-targeted siRNA. However, because RPE cells failed to
undergo transfection, we were not able to clearly demonstrate
that the β-ionone-mediated effects depend on the activation of
OR51E2.
β-Ionone-Induced Signaling in RPE Cells
We next aimed to elucidate the signaling mechanism of the
β-ionone-evoked Ca2+ response in RPE cells. We used a
Ca2+ free Ringer’s solution to determine the origin of the
agonist-evoked Ca2+ increase. The β-ionone-induced Ca2+
rise was almost completely absent after the removal of the
extracellular Ca2+. This suggests that the odorant-evoked
response of RPE cells depends on extracellular Ca2+ and that
the Ca2+ released from intracellular stores does not primarily
contribute to the β-ionone-induced Ca2+ signals (Figure 3A).
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FIGURE 1 | OR51E2 is expressed in human retinal pigment epithelial cells. (A) The heat map shows the FPKM values for the most abundant ORs (mean FPKM > 0.3)
in three whole RPE samples compared to fetal RPE (fRPE), retina supporting tissue (RPE/Choroid/Sclera) and the three neural retina samples (upper panel). The
darker colors indicate higher FPKM values and white indicates the absence of any detectable transcripts. Representation of the read coverage of the OR51E2
transcripts detected in primary RPE cells and visualized by the Integrative Genomic Viewer (lower panel). The gray segments indicate the reads that were mapped
onto the reference genome. The gene is indicated by the blue bars (exon), and thin line (intron) with an arrowhead that shows the reading direction. Read coverage is
shown above (detected and mapped counts/bases at each respective position). (B) Detection of OR51E2 transcripts in primary RPE cells by RT-PCR. Gel
electrophoresis of amplicons from primary RPE cell cDNA (+) and no reverse transcriptase cDNA controls (–) to exclude genomic DNA contamination.
Premelanosome protein (PMEL) and Retinaldehyde-binding protein 1 (RLBP1) expression identifies RPE cells. The amplification of β-actin (ACTB) served as a control
for cDNA quality. (C) Immunofluorescence confocal micrographs of RPE cells labeled with an OR51E2 specific antibody (green) and DAPI to visualize the nuclei (blue).
An intracellular staining of OR51E2 can be observed. The bar indicates 50µm. (D) Plasma membrane localization of OR51E2 in RPE cells verified by surface
biotinylation and detection by Western blotting. A representative Western blot of biotinylated membrane of the RPE cells and melanocytes (NHEM), as a positive
control, is shown. The cytosolic protein GAPDH served as a control for the enrichment of cell surface proteins and lack of cytosolic proteins. (E) Immunofluorescence
confocal micrographs of a histological section of RPE, choroid (Ch) and sclera (S) co-labeled with an OR51E2-specific antibody (red). The bar indicates 50µm.
Measurements with the phospholipase C inhibitor U-73122 did
not reveal significant effects on the β-ionone-induced Ca2+
increase, whereas depletion of calcium stores by thapsigargin
leads to a reduced Ca2+ response after β-ionone stimulation
(Figure 3C, Supplementary Figure S3). The co-application of β-
ionone with the adenylyl cyclase inhibitor SQ 22,536 significantly
diminished β-ionone-induced Ca2+ responses in RPE cells
(Figures 3B,C), indicating a major role of cAMP-signaling after
β-ionone stimulation in this cell type. The quantification of the
signal amplitudes is shown in Figure 3C. The Ca2+ imaging
experiments suggested the involvement of cAMP. Hence, we
examined whether β-ionone affects the intracellular cAMP level
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FIGURE 2 | OR51E2-agonist induces Ca2+ signals in human RPE cells. (A) Representative Ca2+ imaging trace of a primary RPE cell. Horizontal bars indicate time
and duration of stimulus application. β-ionone (100µM) application induces a transient rise in intracellular Ca2+ in the individual cells. ATP (100µM) served as the
positive stimulus to control cell viability. Cytosolic Ca2+ levels were monitored as an integrated f340/f380 fluorescence ratio, which is expressed as a function of time.
In prolonged stimulation, the maximal signal amplitude was reached after a 3min application of β-ionone. β-ionone induced transient Ca2+ signals in primary RPE
cells upon repetitive stimulation. (B) The β-ionone-induced Ca2+ increase is dose-dependent. β-ionone was applied at different concentrations to ensure the maximal
number of responsive cells. The number of responsive cells was normalized to the number of ATP-responsive cells [positive control (n = 5–7)]. (C) Representative
Ca2+ imaging trace of a Fura-2-loaded human RPE cells. Application of β-ionone induces intracellular Ca2+ increase in a dose-dependent manner (upper panel).
Application of the solvent (0.1% DMSO) did not result in any changes in cytosolic Ca2+ level (lower panel). (D) Dose-response curve of the β-ionone-induced Ca2+
signals. The signal amplitude, at the first application, was normalized to the amplitude evoked by ATP and is displayed as a function of the applied β-ionone
concentration. The EC50 value was 91µM. (n = 5–7).
using a cAMP assay. We observed that the odorant application
increased the cAMP level in a dose-dependent manner up to
a maximal response of 40% relative to the response to the
adenylyl cyclase activator forskolin, which served as a positive
control (Figure 3D). In olfactory sensory neurons, ORs couple
to the Golf protein. This results in an activation of adenylyl
cyclase III (AC-III), followed by the generation of cAMP,
which, in turn, leads to the opening of the olfactory CNG
channel (subunits CNGA2, CNGA4 and CNGB1) and to an
influx of Ca2+(Mombaerts, 2004). According to our first results,
we assumed that the OR51E2-initiated signal transduction
mechanism in RPE cells was similar to the canonical olfactory
signaling pathway. In addition, the mRNAseq analysis revealed
that AC-III (ADCY3) and Gαolf (GNAL) were expressed in
the RPE cells (Figure 3E). The RT-PCR results verified the
expression of GNAL and ADCY3, and the products Gαolf and
AC-III were detected at the protein level by Western blotting in
RPE cells (Figures 3E,F). The mRNAseq and RT-PCR analyses
showed that most of the CNG subunits were only low or
not expressed in the RPE cells (Figure 3E, Supplementary
Figure S4).
Effect of the OR51E2 Agonist β-Ionone on
Proliferation and Migration
OR51E2 is involved in the regulation of cell growth, migration
and the invasiveness of skin melanocytes, melanoma cells and
prostate cancer cells (Neuhaus et al., 2009; Rodriguez et al., 2014;
Sanz et al., 2014, 2017; Gelis et al., 2016, 2017). Therefore, we
investigated the effect of the OR51E2 ligand β-ionone on the
migrative and proliferative properties of primary RPE cells. To
study cell migration in vitro, a gap closure assay was performed.
The exposure of RPE cells to β-ionone (10µM and 100µM)
for 24 h and 36 h significantly induced the acceleration of the
regeneration rate of the RPE cell monolayer compared to the
control conditions (cell stimulated with solvent; 0.1% DMSO)
(Figure 4A). In addition to migration, we also observed that β-
ionone promoted RPE cell proliferation. RPE cells were treated
for 5 days in basal medium containing different concentrations
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FIGURE 3 | β-ionone-induced signaling in RPE cells. (A) Representative Ca2+ imaging trace of a Fura-2 loaded-RPE cell. β-ionone-induced signaling depends on
extracellular Ca2+. β-ionone (500µM), applied under Ca2+ free conditions (+1mM EGTA), did not evoke Ca2+ signals. (B) Pre-incubation with the AC inhibitor
SQ-22,536 (100µM) abolished the β-ionone (500µM)-induced Ca2+ signal in Ca2+ imaging experiments. (C) Quantification of the Ca2+ signal amplitudes under
Ca2+ free conditions (n = 5 experiments, each with 4–9 cells), with the inhibitor SQ 22,536 (n = 5, each with 5–9 cells), with U-73221 (n = 4, each with 4–11 cells)
and with thapsigargin (n = 4, each with 6–12 cells), which was normalized to the RPE cell responses to the control stimulations within the same experiments (β-ionone
in Ca2+ containing buffer). (D) β-ionone induces an intracellular increase in the cytosolic cAMP in RPE cells after 15min stimulation in a dose-dependent manner. The
cAMP level was normalized to the AC activator forskolin (positive control) (n = 3). Significance was calculated by Student’s t-test (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤
0.005). (E) The detection of transcripts from the OR-signaling pathway components, including Gαolf (GNAL), AC-III (ADCY3) and CNG channel subunits, in the RPE
cells via mRNAseq and RT-PCR. (F) Verification of the Gαs/olf and AC-III protein expression in the RPE cells by a Western blot.
of β-ionone and the cell number was determined by measuring
DNA content. Long-term β-ionone stimulation significantly
increased the cell number in a dose-dependent manner, even
at sub-micromolar concentrations of β-ionone. The maximal
effect on proliferation (∼30% increase in cell number) was
noticed after a treatment with 10µM β-ionone. This effect on
the cellular proliferation rate was less pronounced at higher
concentrations but was still observable compared to the control
(Figure 4B). This result was confirmed via immunocytochemical
staining with an antibody against the proliferating cell nuclear
antigen as a marker for cell division (Figure 4C). To determine
the signaling components that promotes the proliferation and
migration in RPE cells, we analyzed the activation of protein
kinases that mediate the regulation of various cellular processes
introduced by external signals (Hecquet et al., 2002; Chan
et al., 2013; Qin et al., 2013; Cheng et al., 2014; Su et al.,
2014; Du et al., 2015; Wang et al., 2015). Using the Proteome
Profiler Human Phospho-Kinase Array Kit we investigated the
phosphorylation of 43 different protein kinases in stimulated
vs. control cells. RPE cells were incubated for 30min with β-
ionone or solvent (0.1% DMSO), and the phosphorylation levels
of various kinases were determined (Supplementary Figure S5).
Stimulation with the odorant increased the phosphorylation of
3 kinases (ERK1/2, Extracellular-signal-regulated kinases 1/2;
AKT, Protein kinase B; PRAS40, proline-rich AKT substrate 40
kDa) about the detection threshold (2-fold increase relative to
control) (Figure 4D, Supplementary Figure S5). Western blot
experiments were performed to confirm these results, verifying
the significant enhanced phosphorylation of ERK1/2 and AKT
(Figure 4E).
DISCUSSION
Expression of OR51E2 in the Human RPE
Comparative transcriptome analyses revealed that OR51E2 is
expressed in various human tissues, such as the prostate, colon,
heart and breast (Flegel et al., 2013; Veitinger and Hatt, 2017).
OR51E2 is not only broadly expressed, but it is also one of the
highest expressed ORs at the mRNA transcript level (Flegel et al.,
2013). In addition, OR51E2 was also identified in epidermal
melanocytes and derived melanoma cells, in which the activation
of OR51E2 affects cell-type specific physiological processes, such
as pigmentation and proliferation (Gelis et al., 2016, 2017). In
addition to the basal layer of the epidermis, further cellular layers
exist in the human body, which contain pigmented granules.
These include the RPE, the iris pigment epithelium and the
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FIGURE 4 | β-ionone promotes proliferation and migration of RPE cells. (A) A gap closure assay, using RPE cells, in the presence of 10µM, 100µM or 0.1% DMSO
(control). The open gap area after 12, 24, and 36 h is shown relative to the original gap area at time point 0 h. The 100µM β-ionone treatment significantly enhanced
cell migration compared to the control condition (0.1% DMSO) (right and left panel). (B) The proliferation of the RPE cells after treatment with increasing
concentrations (1µM, 5µM, 10µM, 50µM, and 100µM) of β-ionone for 5 days compared to the control condition. The relative cell number was determined by the
CyQUANT cell proliferation assay. The data are shown as the mean of four independent experiments ± the SEM with technical replicates and were normalized to the
cell number in the control experiments. (C) Immunofluorescence confocal micrographs of the RPE cells labeled with a PCNA-specific antibody (green) and AlexaFluor
546 phalloidin (red) (left panel). Immunocytochemical staining reveals significantly enhanced numbers of proliferating cells after stimulation with β-ionone (10µM and
100µM) compared to the control condition (0.1% DMSO). The data are shown as the mean of three independent experiments using 100 quantified cells for each
experiment, which was normalized to the cell number in the control experiments. (D) The OR51E2 agonist β-ionone induces the phosphorylation of protein kinases in
RPE cells. The Human Phospho-Kinase Array was plotted with proteins from the RPE cells stimulated with β-ionone (500µM; lower panel) or control (0.1% DMSO;
upper panel) for 10min. The specific antibodies against the phosphorylated protein kinases were spotted in duplicate. The colored boxes mark areas where at least a
2-fold increase in the protein signal intensities between the β-ionone-treated cells and the solvent-treated cells (control) was observed. The pixel intensities of the
duplicates were averaged and β-ionone-induced phosphorylation was normalized to the control. The phosphorylation of ERK1/2, AKT and PRAS40 was enhanced
relative to the control (right panel; n = 1). (E) A Western blot analysis verified the phosphorylation of ERK1/2 (T202/Y204, T185/Y187) and AKT kinases (S473) in the
RPE cells after 10 and 30min stimulations with β-ionone (500µM) compared to stimulation with the solvent (0.1% DMSO; control) (right panel). Determination of the
total amounts of the respective kinases served as controls. The mean pixel intensities of the phosphorylated proteins relative to the total protein were quantified and
normalized against the control-treated cells (n = 4). Significance was calculated by Student’s t-test (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.005).
choroid in the human eye. In the present study, we elucidated
the gene expression of OR51E2 in pigment cells of the eye
with a focus on RPE cells. The analysis of the mRNAseq data
revealed the gene expression of OR51E2 in primary RPE cells
of three different donors. Interestingly, OR51E2 showed the
highest expression in adult and fetal RPE cells, whereas this
receptor was not detectable in the human neural retina. The
localization of OR51E2 protein was confirmed in intracellular
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compartments and in the plasma membrane of human RPE cells
using immunocytochemical staining and Western blot analyses.
These findings lead to the assumption that the receptor is
present in intracellular membranes, such as endosomes, and not
exclusively in the plasma membrane.
The presence of OR51E2 beyond the cytoplasmic membrane
was previously demonstrated in human prostate tissue and
in endosomal organelles of melanocytes (Gelis et al., 2016;
Massberg et al., 2016). The intracellular localization of further
ORs was also described for OR2A4, which localized to the
cytokinetic structures of HeLa cells and for other ORs in sperm,
ratina, heart, kidney, and brain (Zhang et al., 2012; Garcia-
Esparcia et al., 2013; Kalbe et al., 2016c; Jovancevic et al.,
2017a,b). Moreover, the intracellular localization and function
of GPCRs in RPE cells was previously shown for the well-
characterized GPCR ocular albinism type 1 (OA1), which is
predominantly localized at the membranes of melanosomes, the
organelles of pigment synthesis, and late endosomes/lysosomes.
At the plasma membrane, only low amounts of this receptor
were detected. OA1 functions in the regulation of melanosome
biogenesis and the secretion of growth factors by transducing
signals through the activation of heterotrimeric G proteins at the
cytoplasmic side of the organelle membrane (Schiaffino et al.,
1999; Schiaffino and Tacchetti, 2005; Lopez et al., 2008; Giordano
et al., 2011).We assume that OR51E2 could be involved in similar
processes.
Furthermore, immunohistochemical staining of retina
sections, including neural retina supporting tissues
(RPE/Choroid/Sclera), confirmed our OR51E2 protein
expression results in the RPE and demonstrated the expression
of OR51E2 in a second pigment layer, the choroid. We did not
detect OR51E2 expression in the neural retina and sclera, and
thus, we hypothesize that this receptor is specifically expressed in
pigment cells of the human eye.
Activation of OR51E2 in RPE Cells
OR51E2 is one of the first de-orphanized human ORs. The
identified carotenoid-derived volatile agonist β-ionone has a
characteristic violet-like smell (Neuhaus et al., 2009). The
OR51E2 agonist β-ionone is a product from the oxidative
cleavage of carotenoids, such as beta-carotene and lycopene,
and is catalyzed by β,β-carotene-9,10-dioxygenase 2 (BCDO2).
BCDO2 belongs to the carotenoid oxygenase family β-carotene
15, 15’-monooxygenase (BCDO1), and its key function is the
conversion of provitamin A carotenoids to vitamin A. Vitamin A
is crucial for physiological functions, such as vision, embryonic
development and cell differentiation (Amengual et al., 2013).
BCDO2 expression is detected in various human tissues, such
as cardiac and skeletal muscle cells, the intestine and especially
in the RPE (Lindqvist et al., 2005). Thus, we assumed that
β-ionone, a cleavage product of the BCDO2 enzyme, may
activate intracellular localized OR51E2. The localization of OR
beyond the plasma membrane was described for OR51E2 and
various other ORs in diverse tissues. However, the function
was only hypothesized except for OR2A4 in cells derived from
cervical cancer, where participation in the cytokinesis was shown
experimentally (Zhang et al., 2012). As most of the canonical
downstream molecules that are involved in the GPCR signal
pathway at the plasmamembrane, such as the G protein, adenylyl
cyclase and Ca2+ channels (Bootman et al., 2009; Garcia-
Esparcia et al., 2013), have also been detected in intracellular
compartments, the activation of a subcellular signaling cascade
may be possible.
Moreover, it is conceivable that OR51E2-activating products
of BCDO2 reach the RPE via the blood flow and may bind
to OR51E2 at the plasma membrane. In addition, the BCDO2
enzyme is expressed in tissues that are not sensitive to vitamin
A deficiency. It was therefore suggested that BCDO2 may
also be involved in physiological processes other than vitamin
A synthesis, pointing toward a potential biological function
of the cleaved products, such as β-ionone (Lindqvist et al.,
2005). Moreover, β-ionone can be found in edible and aromatic
plants as well as in waters, such as lakes and rivers, due
to biotransformation processes in phytoplankton (Jones, 1995;
Gomes-Carneiro et al., 2006; Antonopoulou et al., 2014; Ansari
and Emami, 2016). β-ionone is often used as a fragrance in
cosmetics, such as perfume, soaps and shampoos (Belsito et al.,
2007). Therefore, there are many opportunities for β-ionone to
reach the receptor in RPE cells.
The functional role of the β-ionone-activated OR51E2
was previously described for prostate cancer cells, epidermal
melanocytes and melanoma cells, whereby OR51E2 regulates
the proliferation, migration, invasiveness and pigmentation
(Neuhaus et al., 2009; Rodriguez et al., 2014; Sanz et al., 2014,
2017; Gelis et al., 2016, 2017). Thus, OR51E2 represents an
interesting therapeutic target for the development of novel
therapies to treat cancer or pigmentation disorders (Gelis et al.,
2016, 2017). The activation of OR51E2 in these cells by β-ionone
leads to an increase in intracellular Ca2+ (Neuhaus et al., 2009;
Gelis et al., 2016, 2017). A β-ionone-induced Ca2+ response was
also observed in RPE cells, but it differs in response kinetics
compared to prostate cancer cells, epidermal melanocytes (time
to peak: 5-10min), as well as Hana3A cells, heterologously
expressing OR51E2 (time to peak: few seconds). In the RPE cells,
the maximal amplitude was reached after an average of 3min
of continuous β-ionone application, followed by a decrease in
signal independent of the presence of the ligand. After reaching
basal Ca2+ levels (after ∼2min), the cells were again responsive
to odorant stimulation. The EC50 value of the β-ionone-induced
Ca2+ increase in RPE cells was 91µM. However, this is higher
than in epidermal melanocytes (∼60µM), whereas the dose-
response relationship in prostate cancer cells and melanoma
cells was not described in the respective studies. The different
response kinetics observed in Ca2+ imaging experiments could
be a result of the different experimental conditions and initiation
of different signaling pathways, which seems to depend on the
cellular context in which OR51E2 is expressed. In prostate cancer
cells, OR51E2 activation leads to the opening of the transient
receptor potential vanilloid type 6 channel via amember of the src
kinase family (Spehr et al., 2011). Inmelanocytes the involvement
of cAMP and TRP channels as well as a partial Ca2+ increase
from intracellular stores was suggested (Gelis et al., 2016). The β-
ionone-induced Ca2+ rise in RPE cells is mediated primarily by
cAMP as the key messenger, as shown in Ca2+ experiments with
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pharmacological inhibitors and cAMP assays and secondarily
by Ca2+ release from intracellular stores independent of the
IP3 pathway. In olfactory sensory neurons (OSNs), the OR-
induced signal cascade also involves the activation of AC-III
and the subsequent synthesis of cAMP, which in turn opens
CNG channels (Nakamura and Gold, 1987; Jones and Reed,
1989; Bakalyar et al., 1990). The olfactory specific types of the
G protein and AC-III were identified at the mRNA level in all
analyzed samples and protein levels in RPE cells, but not all
of the three CNG subtypes. The mRNAseq and PCR analysis
revealed a donor dependent expression of the olfactory CNG
subunits. Most of the donor samples do not express all three
subunits that were necessary for the formation of a functional
olfactory-type channel. Instead, we identified rod- and cone-
specific CNG channel subtypes. According to ourmRNAseq data,
these specific subtypes are expressed only at low levels in the RPE
cells (e.g., CNGA1: 0.3 mFPKM; CNGB3: 0.05 FPKM). Thus,
we conclude that the β-ionone-induced pathway in RPE cells
uses similar components as in OSNs with the main difference
of the Ca2+ channel type, which mediates the observed Ca2+
influx. In RPE cells, we suppose that cAMP leads to the activation
of protein kinase A, which in turn opens L-type Ca2+ (e.g.,
CACNA1A: 3.85mFPKM; CACNA1A: 2.63mFPKM) (Rosenthal
and Strauss, 2002) or TRP channels (e.g., TRPM3: 1.71 mFPKM;
TRPM4: 7.76 mFPKM), as shown in epidermal melanocytes and
prostate cancer cells (Spehr et al., 2011; Gelis et al., 2016). Further
pharmacological investigations with specific inhibitors against
these components or siRNA experiments are necessary for a clear
statement.
In addition to the effect on cytosolic Ca2+ homeostasis, β-
ionone induced the activation of several downstream protein
kinases. In prostate cancer cells, OR51E2 activation results
in an activation of protein tyrosine kinase 2 beta (Pyk2),
which in turn leads to the phosphorylation of p38 mitogen-
activated protein kinases (Neuhaus et al., 2009; Wiese et al.,
2015). In epidermal melanocytes, stimulation with β-ionone
leads to the activation of extracellular signal-regulated kinase
(ERK1/2; p42/p44 MAPK) and p38 MAPK (Gelis et al., 2016).
To elucidate the effect of β-ionone on protein kinases in RPE
cells, we used the Proteome Profiler Human Phospho-Kinase
Array Kit to analyze, in parallel, the phosphorylation of 43
different protein kinases, and we confirmed the results via
a Western blot analysis. RPE cells stimulated with β-ionone
lead to the activation of ERK1/2, a finding which is consistent
with the result published for skin melanocytes. Additionally,
we observed an increased phosphorylation of AKT and of its
substrate PRAS40 (Malla et al., 2015), which, in turn, verifies the
AKT activation. An activation of protein kinases after odorant
stimulation was shown in various studies (Busse et al., 2014;
Maßberg et al., 2015; Kalbe et al., 2016d; Weber et al., 2017).
Kim et al. were able to demonstrate that the AKT activation
after stimulation with the OR10J5 agonist lyral depends on the
receptor by the knockdown of OR10J5 in human umbilical
vein endothelial cells (Kim et al., 2015). Key players of the
OR-induced signal pathway leading to the phosphorylation of
kinases were analyzed by specific inhibitors. For example, in
non-small-cell lung cancer cells helional induced a Ca2+ signal
and phosphorylation of ERK1/2 via phosphatidylinositol-4,5-
bisphosphate 3-kinase, whereas in myelogenous leukemia cells
the OR2AT4 ligand sandalore evoked an increase in intracellular
Ca2+ level, which activated CaMKII and initiated ERK1/2 and
AKT phosphorylation. Therefore, there are different possibilities
how OR activation could lead to an enhanced protein kinase
phosphorylation. We assume that, also in RPE cells, ERK1/2 and
potentially AKT are activated via CaMKII or cAMP asmentioned
in other studies (Bos, 2003; Dumaz andMarais, 2005; Namkoong
et al., 2009). A variety of studies described the physiological effect
of AKT and ERK1/2 activation in RPE cells. In both cases, the
activation leads to the promotion of migration and proliferation
of RPE cells (Hecquet et al., 2002; Chan et al., 2013; Qin et al.,
2013; Su et al., 2014; Du et al., 2015). The effect of β-ionone
on RPE cells differs from melanocytes, since AKT, but not p38
MAPK, is activated. In contrast to AKT, p38 MAPK inhibits the
growth of RPE cells (Hecquet et al., 2003; Chen et al., 2016).
Moreover, AKT-activation is involved in the protection of RPE
cells from oxidative stress (Cheng et al., 2014; Wang et al., 2015).
Furthermore, Ca2+ as a second messenger is involved in the
regulation of RPE functions, such as proliferation, secretion of
the growth factor vascular endothelial growth factor (VEGF), and
pigmentation (Smith-Thomas et al., 1998; Reichhart and Strauss,
2014).
Possible Role of OR51E2 in the RPE Cells
The observed effects of β-ionone on Ca2+ homeostasis and
protein kinase activation is in accordance with the observation
that a β-ionone-induced an increased proliferation andmigration
of primary RPE cells. The involvement of OR51E2 in the
secretion process of growth factors, such as pigment epithelium-
derived factor (PEDF) and VEGF, as well as in the protection
from oxidative stress was investigated, but revealed no effect
upon β-ionone stimulation (data not shown). A reduced
proliferation rate, as a result of OR51E2 activation, was observed
in melanocytes, melanoma cells and prostate cancer cells
(Neuhaus et al., 2009; Gelis et al., 2016, 2017). Interestingly,
stimulation of RPE cells with the OR51E2 agonist led to the
opposite effect, namely, to an increased proliferation. Different
physiological outcomes after activating the same OR in different
cell types were previously observed for OR2AT4. The activation
of OR2AT4 by its agonist sandalore results in an enhanced
proliferation of keratinocytes, whereas the activation of the
same receptor in chronic myelogenous leukemia cells leads to a
reduced proliferation and an induction of apoptosis (Busse et al.,
2014; Manteniotis et al., 2016a). An opposite physiological effect
can be explained by the fact that OR activation in the respective
cell type triggers different signal cascades. In RPE cells, β-ionone
leads to the activation of a cAMP-mediated influx of extracellular
Ca2+ that results in an activation of AKT-dependent signaling
and finally to an increased proliferation rate. In contrast, the
activation of OR51E2 in melanocytes triggers cAMP-mediated
influx of extracellular Ca2+, as well as a release of Ca2+ from
intracellular stores with an activation of p38 MAPK. We assume
that this activation of p38 MAPK leads to the OR51E2-induced
reduction of the proliferation rate in melanocytes. Therefore, the
respective physiological effect depends on the cellular repertoire.
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Moreover, the regulation of migration and invasiveness via
OR51E2 was described in melanoma and prostate cancer cells
(Sanz et al., 2014; Gelis et al., 2017). Stimulation of RPE cells
with the OR51E2 agonist β-ionone led to enhanced migration,
whereas the invasiveness of the RPE cells was unaffected (data
not shown). The involvement of OR51E2 in the pigmentation of
melanocytes was previously shown (Gelis et al., 2016). Because
we observed a cell type-specific expression of OR51E2 in the
investigated pigment cells of the eye, but not in neural retina
and sclera, an analysis of the involvement of OR51E2 in cell
pigmentation would be of interest. However, the pigmentation
ability of primary RPE cells disappears during preparation and
cultivation (Kernt et al., 2010). Therefore, it is not possible
to analyze the role of OR51E2 in melanogenesis in primary
human RPE cells. The receptor dependency of the physiological
effects induced by odorants was shown in few cases by siRNA
knockdown (Busse et al., 2014; Kim et al., 2015) or experiments
with antagonist (Spehr et al., 2003; Neuhaus et al., 2009; Gelis
et al., 2016; Kalbe et al., 2016a; Manteniotis et al., 2016a). Due to
experimental difficulties, these methods could not be successfully
transferred to primary RPE cells. Moreover, the analyzation of the
β-ionone-induced observed pharmacological effects on human
RPE cells using knockout mice was not possible. β-ionone does
not activate the OR51E2 mouse ortholog Olfr78 (Pluznick et al.,
2013). It is worth noting that Olfr78 knockout mice were used
to demonstrate that the activation of Olfr78 with other ligands
(short chain fatty acids or lactate) affects various physiological
processes for example the renin secretion (Pluznick et al., 2013;
Chang et al., 2015; Aisenberg et al., 2016). Aisenberg et al.
could also show via CRISPR/Cas9 system that Olfr78 is involved,
whereas the results with OR51E2-edited human airway smooth
muscle cells are not clear (Aisenberg et al., 2016). In order
to ensure that the observed effects of β-ionone involved the
activation of OR51E2, the establishment of the CRISPR/Cas9
technology in primary human RPE cells would be necessary in
future studies.
Taken together, to the best of our knowledge, we are
the first that detect OR51E2 as the most highly expressed
OR in human adult and fetal RPE. Moreover, we identified
OR51E2 on protein level in a further pigment cell layer
of the eye, the choroid. We demonstrated that the OR51E2
agonist β-ionone induces an intracellular Ca2+ increase and the
phosphorylation of the protein kinases AKT and ERK1/2. We
also showed that adenylyl cylase and cAMP primarily mediate
the Ca2+ increase, which indicates an involvement of an OR.
Moreover, the fact that further OR51E2-activating substances
evoked a Ca2+ response and non-activating substances had
no effect on the Ca2+ level strengthened the assumption
that OR51E2 is involved. Lastly, we provided insights into
the potential role of OR51E2 in RPE cell physiology, which
may be the regulation of proliferation and migration. Based
on these findings, we suggest that OR51E2 acts similar
to growth factor receptors in RPE cells and induces the
proliferative/wound-healing responses. Therefore, we conclude
that OR51E2 represents a promising therapeutic target protein
for the treatment of proliferative RPE disorders, such as
proliferative vitreoretinopathy (Andrews et al., 1999; Pennock
et al., 2014).
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